Co-author; Research Professor of Cardiovascular Medicine, University of Michigan
Appears in 2 stories
Co-inventor on the DT-109 patent
Severe fatty liver disease has almost no drugs that reverse it. On July 11, 2026, a University of Michigan team reported that an experimental compound called DT-109 did exactly that in mice and monkeys, by fixing the gut instead of the liver.
Updated Jul 11
Investigator at the Broad Institute, MIT, and Howard Hughes Medical Institute
Every major tool in genetic engineering — from the enzymes that cut DNA in the 1970s to CRISPR gene editing — started as a defense weapon bacteria use against viruses. Two teams revealed bacteria carry three times more weapons than anyone realized, identifying millions of antiviral proteins from tens of thousands of genomes using machine-learning models that flag a new defense system in five minutes.
Updated May 31
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
